Mirae Asset Global Investments
DICE

Mirae Asset Global Investments’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Mirae Asset Global Investments’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,488
Closed -$766K – 2674
2023
Q2 		$766K Sell
16,488
-97
-0.6% -$3.35K ﹤0.01% 1727
2023
Q1 		$475K Sell
16,585
-30
-0.2% -$889 ﹤0.01% 1953
2022
Q4 		$518K Buy
16,615
+4,808
+41% +$157K ﹤0.01% 1872
2022
Q3 		$239K Buy
+11,807
New +$215K ﹤0.01% 2266

Mirae Asset Global Investments's DICE Position: Q3 2023 in Review

Mirae Asset Global Investments sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 16,488 shares — an estimated $766K sold.

Mirae Asset Global Investments first reported a position in DICE in Q3 2022 and held it in 4 quarters. The position peaked at $766K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Mirae Asset Global Investments reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 16,488 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $766K.
  • Mirae Asset Global Investments first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • Mirae Asset Global Investments's DICE Therapeutics, Inc. Common Stock position peaked at $766K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Mirae Asset Global Investments's 13F filing for Q3 2023, filed 26 Oct 2023.